Ventus Therapeutics
PrivateLast Round
Series C
Feb 9, 2022
Total Funding Raised
$300M
Momentum Score
25 /100
Company Overview
Ventus Therapeutics is a biopharmaceutical company specializing in structural immunology-based therapeutics that develop small-molecule medicines targeting proteins in inflammasome and nucleic acid-sensing signaling pathways to address acute and chronic inflammatory and immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ventus Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Ventus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 9, 2022 | ||||
| Series B | Apr 8, 2021 | ||||
| Series A | May 6, 2020 |
Key People
Founding team and executive leadership
Ventus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C |
| SoftBank Investment Advisers | Series C |
| RA Capital Management | Series C, Series B |
| GV | Series C, Series A, Series B |
| Fonds de solidarité FTQ | Series C, Series B |
| SoftBank Group | Series C |
| Versant Ventures | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2025
Partnered with Genentech to develop small-molecule drugs.
- Sep 4, 2025
Will present at the Morgan Stanley Global Healthcare Conference.
Ventus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ventus Therapeutics's valuation, stock price, and market status.
